VeriSIM Life

VeriSIM Life is an AI-first biotechnology company transforming drug development through predictive biosimulation. Its BIOiSIM platform combines hybrid AI/machine learning with mechanistic biological models and its Translational Index to predict drug efficacy, safety and translatability across species and virtual populations. It also offers AtlasGEN generative drug design, platform-enabled services, risk-sharing partnerships for co-developing drug assets, and PulmoSIM Therapeutics, a wholly-owned brand that identifies licensable preclinical candidates.